Substantial reduction in the clinical and economic burden of disease following variant-adapted mRNA COVID-19 vaccines in immunocompromised patients in France
Preprint in medRxiv (March 2024)
The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.
Preprint in medRxiv (March 2024)
Article in Journal of Clinical Epidemiology (March 2024)
Article in Vaccines (October 2023)